Policy paper

Methylphenidate-based novel psychoactive substances: temporary class drug order recommendations

Recommendations for a temporary class drug order on a number of methylphenidate-based novel psychoactive substances.

From:
Advisory Council on the Misuse of Drugs
Published
8 April 2015
Last updated
23 March 2017 鈥� See all updates

Documents

PDF, 164 KB, 3 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 109 KB, 12 pages

PDF, 13.7 KB, 1 page

PDF, 111 KB, 3 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 435 KB, 16 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

皇冠体育appse documents outline recommendations from the Advisory Council on the Misuse of Drugs (ACMD) on controlling a number of methylphenidate-based novel psychoactive substances (NPS) under a temporary class drug order.

You can also download a follow-up recommendation from the ACMD from February 2016 which advises on an extension of a temporary class drug order for methylphenidate-based NPS.

Updates to this page

Published 8 April 2015
Last updated 23 March 2017 show all updates

  1. Letter of 23 March, detailing final scheduling advice, published.

  2. Published further advice on methylphenidate-related NPS.

  3. Follow up recommendation from the ACMD on methylphenidate-based NPS published.

  4. Addendum published.

  5. First published.

Sign up for emails or print this page